Peptides, without the jargon
The word “peptide” describes a broad family, not one type of product. Some are proven prescription medicines. Some are topical cosmetic ingredients. Many popular online compounds are still unapproved or experimental.
Supported for specific approved medical indications.
Currently being studied in controlled research settings
Shows emerging promise and suitable for further investigational study
Guided discovery
Choose one area
Eight areas to explore
The Lion catalogue
Each card presents a recognised peptide alongside its evidence and access context. Some peptides have established medical uses; others are investigational or remain in earlier-stage research. Each named vial is a representative LION PEPTIDES illustration only and does not depict actual product packaging. Packaging, presentation and labelling may vary by authorised manufacturer, jurisdiction and documented product information where applicable.
Metabolic healthRepresentative imageGLP-1 analogue
An established medicine used for appetite, weight and metabolic management in approved settings.
Evidence view
Strong evidence for approved indications; medical screening and monitoring are required.
Format: Injection; approved oral tablet in some settings
More information
Metabolic healthRepresentative imageDual GIP/GLP-1 agonist; LY3298176
An established dual-pathway medicine used for obesity and diabetes indications.
Evidence view
Strong evidence for approved obesity and diabetes indications.
Format: Subcutaneous injection
More information
Metabolic healthRepresentative imageGLP-1 analogue
A daily GLP-1 medicine used for weight management and diabetes in approved settings.
Evidence view
Established medicine, generally with less weight loss than newer weekly agents.
Format: Subcutaneous prefilled pen
More information
Metabolic healthRepresentative imageLY-3437943
A triple-receptor agonist being studied for weight and metabolic outcomes.
Evidence view
Investigational; efficacy and safety remain under controlled study.
Format: Once-weekly injection in clinical trials
More information
Metabolic healthRepresentative imageAM833
A long-acting amylin analogue being investigated for appetite and weight management.
Evidence view
Investigational and limited to research protocols.
Format: Subcutaneous injection in trials
More information
Metabolic healthRepresentative imageBI 456906
A dual-pathway compound being studied for weight and metabolic liver health.
Evidence view
Promising but investigational; long-term safety is still being evaluated.
Format: Subcutaneous injection in trials
More information
Metabolic healthRepresentative imageALT-801
A GLP-1/glucagon dual agonist under study for weight and liver-fat reduction.
Evidence view
Investigational with no approved treatment regimen.
Format: Subcutaneous injection in trials
More information
Metabolic healthRepresentative imageModified hGH fragment 176–191
A modified growth-hormone fragment promoted for fat loss.
Evidence view
Human efficacy is not established; safety and product-quality concerns remain.
Format: Injectable powder; oral and topical forms marketed
More information
Metabolic healthRepresentative image44-amino-acid GHRH analogue
A specialist medicine for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.
Evidence view
Evidence-based only for its narrow approved indication—not ordinary weight loss.
Format: Reconstituted subcutaneous injection
More information
Metabolic healthRepresentative imageAmylin analogue
An approved diabetes medicine that influences mealtime glucose and appetite.
Evidence view
Not a general weight-loss product and carries important hypoglycaemia risk with insulin.
Format: Subcutaneous pen injection
More information
Body compositionRepresentative imageGRF 1–29
A growth-hormone-releasing factor associated with GH stimulation, sleep and recovery claims.
Evidence view
Limited evidence for anti-ageing, recovery or body-composition claims.
Format: Usually compounded injection; intranasal forms marketed
More information
Body compositionRepresentative imageCJC-1295
A long-acting experimental GHRH analogue promoted for GH and body-composition effects.
Evidence view
Limited human evidence with unresolved systemic safety concerns.
Format: Injectable lyophilised powder
More information
Representative illustrationInjectable pen devices
A compatible injectable pen may offer a more convenient and structured administration format when it is supplied or authorised for the exact medicine and used according to manufacturer instructions and appropriate professional guidance. A pen does not remove the need for clinical assessment or product-specific training.
Handling may feel more organised for some compatible presentations, but ease and suitability depend on the complete medicine-and-device system.
Formulation, cartridge or prefilled presentation, market authorisation and manufacturer instructions must all be checked before compatibility can be confirmed.
Product-specific video guidance is deferred until suitable approved material is available.
Quality must be evidenced
Lion Peptides aims to work with reputable pharmaceutical and specialist manufacturing sources operating under stringent processes. Specific supplier, manufacturing and testing claims will only be made when supporting documents are available for the relevant product and batch.
Named manufacturer and traceable supply chain.
Relevant identity, purity and safety documentation.
Clear prescription, trial, research or cosmetic classification.
Storage, transport and product-specific documentation.
No certification, batch release, supplier relationship or product availability is asserted on this preview because those documents were not supplied.
Order and consultation requests
Every catalogue entry can be placed in a non-binding request basket for review. Status and the applicable pathway are disclosed in the basket before submission. Trial-only and unapproved research compounds remain excluded from direct checkout.
Dedicated request page
The request page lets all 70 catalogue entries enter a review basket, then discloses status and routing before submission. Restricted selections require an acknowledgement and cannot progress to direct checkout. No payment, prices, stock, shipping or checkout totals are included.
Open ordering pageSubmission is not payment, an order confirmation, a prescription or a guarantee of availability or supply.
